- Reuters•9 days ago
Valeant's U.S.-listed shares (VRX.N) rose as much as 14 percent on Tuesday, before paring gains to 5.7 percent at $16.22 in afternoon trading. Laval, Quebec-based Valeant has been the subject of recent investigations by congressional panels as well as the Federal Trade Commission and the U.S. Securities and Exchange Commission. French cosmetics group L'Oreal (OREP.PA) is buying CeraVe, AcneFree and Ambi from Valeant for about $1.3 billion in cash.
- Benzinga•9 days ago
Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) announced an agreement to sell its CeraVe, AcneFree and AMBI Skincare brands to L'Oreal SA (ADR) (OTC: LRLCY ) for $1.3 billion. According to Gadfly's Andrea ...
- TheStreet.com•9 days ago
L'Oreal just wrote a huge check to Valeant.
OR.PA : Summary for L''OREAL - Yahoo Finance
L'Oréal S.A. (OR.PA)
Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
|Bid||167.00 x 6000|
|Ask||169.85 x 35000|
|Day's Range||169.25 - 170.00|
|52 Week Range||144.15 - 177.90|
|PE Ratio (TTM)||33.10|
|Dividend & Yield||3.57 (1.96%)|
|1y Target Est||N/A|